Companies

Celgene

NASDAQ: CELG
$108.24
▲ $0.00 (+0.00%) today
Markets open · 1:00pm ET

CELG Coverage

Page 23
11:50am ET
Investing

Top Biotechs Set to Win in the War on Cancer

ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech analysts at…

Lee Jackson
7:30am ET
Health and Healthcare

Top New Biotech Ideas From PropThink

ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference between…

Trey Thoelcke
8:10am ET
Health and Healthcare

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain…

Jon C. Ogg
12:50pm ET
Health and Healthcare

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed very well…

Jon C. Ogg